The new iteration of C3 Pharmaceuticals, Inc. announced that it executed a tailored Share Subscription Agreement (SSA) with ...

With school back in session, Purdue University saw a record number of applicants. Wall Street analyst Jane King says Purdue ...

Cerapedics Inc., a global, commercial-stage orthopedics company dedicated to redefining the standard of care for bone repair, today announced the U.S. Food and Drug Administration (FDA) approval for ...

After multiple tests and ultrasounds, doctors discovered multiple lesions on her liver. Biopsies revealed that Ayesha had stage 4 cholangiocarcinoma, a rare form of bile duct cancer that had spread to ...

It was a busy week for the biotech sector with a lot of important data readouts at the European Society for Medical Oncology (“ESMO”) by several companies. Other updates were also in focus. Among ...

Novartis has chalked up another clinical trial win for its targeted factor B inhibitor iptacopan as it strives to position the drug as a patient ... and rare kidney diseases C3 glomerulopathy ...

so that could hand an advantage to Novartis' drug. There's other competition looming in PNH however, as Apellis Pharmaceuticals won FDA approval last month for its C3 inhibitor Empaveli ...

In response to an armed robbery report, Springfield Police apprehended three suspects and seized a large-capacity firearm ...

Synergy Spine Solutions Ltd, an innovative orthopedic medical device developer focused on artificial cervical disc ...

C3.ai Inc’s (NYSE:AI) shift to a consumption-based pricing model, which has lowered the average contract value, is also making the company’s long-term revenue growth less predictable.

The state of Illinois collected $417.6 million in sales taxes from Illinois adult use cannabis dispensaries in 2023, per the ...